Immunochemical identification of mouse hepatic protein adducts derived from the nonsteroidal anti-inflammatory drugs diclofenac, sulindac, and ibuprofen

Chemical Research in Toxicology

Volumn 10, Issue 5, 1997, Pages 546-555

  Wade, Lara T ^a   Kenna, J Gerald ^a   Caldwell, John ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; DICLOFENAC; IBUPROFEN; KEYHOLE LIMPET HEMOCYANIN; NONSTEROID ANTIINFLAMMATORY AGENT; SULINDAC;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG CROSS REACTIVITY; DRUG PROTEIN BINDING; ENZYME ACTIVITY; INTRAHEPATIC BILE DUCT; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER; LIVER TOXICITY; MOUSE; NONHUMAN; PROTEIN MODIFICATION; RABBIT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DICLOFENAC; FEMALE; IBUPROFEN; IMMUNE SERA; IMMUNOBLOTTING; IMMUNOCHEMISTRY; LIVER; MICE; MICE, INBRED STRAINS; PROTEINS; RABBITS; SULINDAC;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0031011809     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx960153t     Document Type: Article

References (50)

1. Katz, L. M., and Love, P. Y. (1992) NSAIDs and the liver. In Therapeutic applications of NSAIDs: Subpopulations and new formulations (Famaey, J. P., and Paulus, H. E., Eds.) pp 247-263, Marcel Dekker, New York.
2. Zimmerman, H. J. (1994) Hepatic injury associated with nonsteroidal anti-infammatory drugs. In Nonsteroidal antiinflammatory drugs. Mechanisms and clinical use (Lewis, A. J., and Furst, D. E., Eds.) pp 171-194, Marcel Dekker Inc., New York.
3. Lewis, J. H. (1984) Hepatic toxicity of nonsteroidal anti-inflammatory drugs. Clin. Pharmacol. 3,128-135.
4. Tarzi, E. M., Harter, J. G., Zimmerman, H. J., Ishak, K. G., and Eaton, R. A. (1993) Sulindac-associated hepatic injury: Analysis of 91 cases reported to the Food and Drug Administration. Gastroenterology 104, 569-574.
5. Scully, L. J., Clarke, D., and Barr, R. J. (1993) Diclofenac induced hepatitis. 3 Cases with features of autoimmune chronic active hepatitis. Digest. Dis. Sci. 38, 744-751.
6. Banks, A. T., Zimmerman, H. J., Ishak, K. G., and Harter, J. G. (1995) Diclofenac-associated hepatotoxicity: Analysis of 180 cases reported to the food and drug administration as adverse reactions. Hepatology 22, 820-827.
7. Boelsterli, U. A., Zimmerman, H. J., and Kretz-Rommel, A. (1995) Idiosyncratic liver toxicity of nonsteroidal antiinflammatory drugs: Molecular mechanisms and pathology. Crit. Rev. Toxicol. 25, 207-235.
8. Spahn-Langguth, H., and Benet, L. Z. (1992) Acyl glucuronides revisited: Is the glucuronidation process a toxification as well as a detoxification mechanism. Drug Metab. Rev. 24, 5-47.
9. Lecoeur, S., Bonierbale, E., Challine, D., Gautier, J.-G., Valadon, P., Dansette, P. M., Catinot, R., Ballet, F., Mansuy, D., and Beaune, P. H. (1994) Specificity of in vitro covalent binding of tienilic acid metabolites to human liver microsomes in relationship to the type of hepatotoxicity: Comparison with two directly hepatotoxic drugs. Chem. Res. Toxicol. 7, 434-442.
10. Hertz, R., and Bar-Tana, J. (1988) The acylation of proteins by xenobiotic amphipathic carboxylic acids in cultured rat hepatocytes. Biochem. J. 254, 39-44.
11. Pumford, N. R., Myers, T. G., Davila, J. C., Highet, R. J., and Pohl, L. R. (1993) Immunochemical detection of liver protein adducts of the nonsteroidal anti-inflammatory drug diclofenac. Chem. Res. Toxicol. 6, 147-150.
12. Hargus, S. J., Amouzedeh, H. R., Pumford, N. R., Myers, T. G., McCoy, S. C., and Pohl, L. R. (1994) Metabolic activation and immunochemical localization of liver-protein adducts of the nonsteroidal anti-inflammatory drug diclofenac. Chem. Res. Toxicol. 7, 575-582.
13. Kretz-Rommel, A., and Boelsterli, U. A. (1993) Diclofenac covalent protein binding is dependent on acyl glucuronide formation and is inversely related to P450-mediated acute cell injury in cultured rat hepatocytes. Toxicol. Appl. Pharmacol. 120, 155-161.
14. Kretz-Rommel, A., and Boelsterli, U. A. (1993) Selective protein adducts to membrane proteins in cultured rat hepatocytes exposed to diclofenac: radiochemical and immunochemical analysis. Mol. Pharmacol. 45, 237-244.
15. Gil, M. L., Ramirez, M. C., Terenico, M. C., and Castell, J. V. (1995) Immunochemical detection of protein adducts in cultured human hepatocytes exposed to diclofenac. Biochim. Biophys. Acta 1272, 140-146.
16. (1994) Relative safety of oral non-aspirin NSAIDs. Curr. Prob. Pharmacovigilance 20, 9-11.
17. Habeeb, A. F. S. A. (1966) Determination of free amino groups in proteins by trinitrobenzene sulfonic acid. Anal. Biochem. 14, 328-336.
18. Kenna, J. G., Neuberger, J., and Williams, R. (1984) An enzyme-linked immunosorbent assay for detection of antibodies against halothane altered hepatocyte antigens. J. Immunol. Methods 75, 3-14.
19. Voller, A., Bidwell, D. E., and Bartlett, A. (1979) The enzyme-linked immunosorbent assay (ELISA). Dynatech Europe, U.K.
20. Touster, O., Aronson, N. N., Dulaney, J. T., and Hendrickson, H. (1970) Isolation of rat liver plasma membranes. Use of nucleotide pyrophosphatase and phosphodiesterase I as marker enzymes. J. Cell Biol. 47, 604-618.
21. 2+ transport by rat liver plasma membrane vesicles. J. Biol. Chem. 259, 1382-1385.
22. LaemmLi, U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
23. Williams, C. H., and Kamin, H. (1962) Microsomal triphosphopyridine nucleotide-cytochrome c reductase of liver. J. Biol. Chem. 237, 587-595.
24. Ali, N., Aligue, R., and Evans, W. H. (1990) Highly purified bile canalicular vesicles and lateral plasma membranes isolated from rat liver on Nycodenz gradients. Biochemical and immunolocalization studies. Biochem. J. 271, 185-192.
25. Sciot, R., Verhoevon, G., Van Eyken, P., Cailleau, J., and Desmet, V. J. (1990) Transferrin receptor expression in rat liver: Immunohistochemical and biochemical analysis of the effect of age and iron storage. Hepatology 11, 416-427.
26. Levine, D. S., and Woods, J. W. (1990) Immunolocalization of transferrin and transferrin receptor in mouse small intestinal absorptive cell. J. Histochem. Cytochem. 38 (6), 851-858.
27. Evans, W. H. (1980) A biochemical dissection of the functional polarity of the plasma membrane of the hepatocyte. Biochim. Biophys. Acta 604, 27-64.
28. Davies, E. F., and Avery, G. S. (1971) Ibuprofen: A review of its pharmacological properties and therapeutic efficacy in rheumatic disorders. Drugs 2, 416-446.
29. Lenga, R. E., (1988) The Sigma-Aldrich Library of Chemical Safety Data, p 3208, Sigma-Aldrich Corp.
30. Riess, W., Stielin, H., Degen, P., Faigle, W., Gerardin, A., Moppert, J., Sallman, A., Schmid, K., Schweizer, A., Sulc, M., Theobald, W., and Wagner, J. (1978) Pharmacokinetics and metabolism of the anti-inflammatory agent Voltaren. Scand. J. Rhuematol. Suppl. 22,17-29.
31. Hucker, H. B., Stauffer, S. C., White, S. D., Rhodes, R. E., Arison, B. H., Umbenhauer, E. R., Bower, R. J., and McMahon, F. G. (1973) Physiological disposition and metabolic fate of a new anti-inflammatory agent, cis-5-fluoro-2-methyl-1-[p-(methylsulfinyl)-benzylidenyl]-indene-3-acetic acid in the rat, dog, Rhesus monkey, and man. Drug Metab. Dispos. 1, 721-736.
32. Mills, R. F. N., Adams, S. S., Cliffe, E. E., Dickinson, W., and Nicholson, J. S. (1973) The metabolism of ibuprofen. Xenobiotica 3, 589-598.
33. Castillo, M., and Smith, P. C. (1995) Disposition and reactivity of ibuprofen and ibufenac acyl glucuronides in vivo in the Rhesus monkey and in vitro with human serum albumin. Drug Metab. Dispos. 23, 566-572.
34. Kretz-Rommel, A., and Boelsterli, U. A. (1994) Mechanism of covalent adduct formation of diclofenac in rat hepatic microsomal proteins. Retention of the glucuronic acid moiety in the adduct. Drug Metab. Dispos. 22, 956-961.
35. Benet, L. Z., Spahn-Langguth, H., Iwakawa, S., Volland, C., Mizuma, T., Mayer, S., Mutschler, E., and Lin, E. T. (1993) Predictability of the covalent binding of acidic drugs in man. Life Sci. 53, 141-146.
36. Hutt, A. J., and Caldwell, J. (1983) The metabolic chiral inversion of 2-arylproprionic acids - a novel route with pharmacological consequences. J. Pharm. Pharmacol. 35, 693-704.
37. Caldwell, J., and Marsh, M. V. (1983) Interrelationships between xenobiotic metabolism and lipid biosynthesis. Biochem. Pharmacol. 32, 1667-1672.
38. Leeman, T., Transon, C., and Dayer, P. (1993) Cytochrome P450TB (CYP2C): A major monoxygenase catalyzing diclofenac 4′-hydroxylation in human liver. Life Sci. 52, 29-34.
39. Meijer, D. K. F. (1989) Transport and metabolism in the hepatobiliary system. In Handbook of Physiology. The gastrointestinal system (Schulz, S. G., Forte, J. G., and Rauner, B. B., Eds.) pp 717-758, Oxford University Press, New York.
40. Knights, K. M., and Jones, M. E. (1992) Inhibition kinetics of hepatic microsomal long chain fatty acid-CoA ligase by 2-aryl proprionic acid non-steroidal anti-inflammatory drugs. Biochem. Pharmacol. 43, 1465-1471.
41. Tracey, T. S., Wirthwein, D. P., and Hall, S. D. (1993) Metabolic inversion of (R)-ibuprofen. Formation of ibuprofenyl-Coenzyme A. Drug Metab. Dispos. 21, 114-120.
42. Stierlen, H., and Faigle, J. W. (1979) Biotransformation of diclofenac sodium (Voltaren) in animals and man. II Quantitative determination of the unchanged drug and principal phenolic metabolites in urine and bile. Xenobiotica 9, 611-621.
43. Sippel, C. J., Suchy, F. J., Ananthanarayanan, M., and Perimutter, D. H. (1993) The rat liver ecto-ATPase is also a canalicular bile acid transport protein. J. Biol. Chem. 268, 2083-2091.
44. Ruetz, S., Fricker, G., Hugentobler, G., Winterhalter, K., Kurz, G., and Meier, P. J. (1987) Isolation and characterisation of the putative canalicular bile salt transport system of rat liver. J. Biol. Chem. 262, 11324-11330.
45. Oude Elferink, R. P. J., Meijer, D. K. F., Kuipers, F., Jansen, P. L. M., Groen, A. K., and Groothuis, G. M. M. (1995) Hepatobiliary secretion of organic compounds; molecular mechanisms of membrane transport. Biochim. Biophys. Acta 1241, 215-268.
46. Paulusma, C. C., Bosma, P. J., Zaman, G. J. R., Bakker, C. T. M., Otter, M., Scheffer, G. L., Scheper, R. J., Borst, P., and Oude Elferink, R. P. J. (1996) Congenital jaundice in rats with a mutation in a multidrug resistence-associated protein gene. Science 271, 1126-1128.
47. Bailey, M. J., and Dickinson, R. G. (1996) Chemical and immunochemical comparison of protein adduct formation of carboxylate drugs in rat liver and plasma. Chem. Res. Toxicol. 9, 659-666.
48. Hargus, S. J., Martin, B. M., George, J. W., and Pohl, L. R. (1995) Covalent modification of rat liver dipeptidyl-peptidase IV (CD26) by the nonsteroidal anti-inflammatory drug diclofenac. Chem. Res. Toxicol. 8, 993-996.
49. Boelsterli, U. A. (1993) Specific targets of covalent drug-protein interactions in hepatocytes and their toxicological significance in drug-induced liver injury. Drug Metab. Rev. 25 (4), 395-451.
50. Kretz-Rommel, A., and Boelsterli, U. A. (1995) Cytotoxic activity of T-cells and non-T cells from diclofenac-immunized mice against cultured syngeneic hepatocytes exposed to diclofenac. Hepatology 22, 213-222.